ZANTE GREG

PrivateCIK: 1264949
Location

RICHMOND, CA

ZANTE GREG (Chief Financial Officer) sold 23.3% of their position (57.66K shares) of VIKING THERAPEUTICS, INC. on the open market

Open‑market sale worth $1.90M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderZANTE GREGCIK 1264949
IssuerVIKING THERAPEUTICS, INC.CIK 1607678
Officer· Chief Financial Officer
Since Jan 2021
+106.39K
Net shares
Net buyer
$1.90M
Total sold
4
Open market trades
0B · 4S
7
Total transactions
164.05K acquired · 57.66K disposed
Non-Derivative Transactions6

Common Stock, par value $0.00001 per share

Direct
A · Award

Shares

+41K

Price / share

Trade value

% of position

23.5%
1/2/2026
174.48K215.48K

Common Stock, par value $0.00001 per share

Direct
A · Award

Shares

+32.05K

Price / share

Trade value

% of position

14.9%
1/2/2026
215.48K247.53K

Common Stock, par value $0.00001 per share

Direct
S · Sale

Shares

31.96K

Price / share

$32.30

Trade value

$1.03M

% of position

12.9%
1/5/2026
247.53K215.57K

Common Stock, par value $0.00001 per share

Direct
S · Sale

Shares

13.90K

Price / share

$33.38

Trade value

$464.02K

% of position

6.4%
1/5/2026
215.57K201.67K

Common Stock, par value $0.00001 per share

Direct
S · Sale

Shares

10.30K

Price / share

$34.24

Trade value

$352.63K

% of position

5.1%
1/5/2026
201.67K191.37K

Common Stock, par value $0.00001 per share

Direct
S · Sale

Shares

1.50K

Price / share

$32.09

Trade value

$48.13K

% of position

0.8%
1/5/2026
191.39K189.89K
Total

Net shares

+15.39K

Net value

-$1.90M

Derivative Transactions1

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

91K shares

Shares

+91K

Strike price

35.42

Held after

91K

Exercisable

1/2/2026